Teva completes Anda acquisition

JERUSALEM — Teva on Monday announced that it had completed its acquisition of generics distributor Anda from Allergan. When the acquisition was announced, it was valued at $500 million, and it brings under Teva’s ownership the fourth-largest U.S. generics distributor. 

 

“We are pleased that Anda, one of the leading distributors of generic medicines in the U.S., is now part of Teva,” president and CEO of Teva’s global generic medicines division. “This acquisition reflects our continued view that attractive growth opportunities, both external and organic, exist for our business and for our extensive supply chain network in particular. This acquisition enables us and our customers to provide more patients throughout the country with access to generic medicines.”

 

Anda president and CEO Charles Phillips said, “We are excited to become part of Teva’s distribution network to support our customers and patients across the country. By joining forces with Teva, Anda’s product offerings will significantly increase and we will be able to reach more patients in the United States.”